IL7 and neoplasm: Firstly, we established a subcutaneous tumor model in mice using the U-87MG-Luc cell line by randomly grouping the mice and intravenously injecting them with 100 μL of SINV IL-12/IL-7 (1.0 × 107 PFU) on days 7, 9, and 11 after cell transplantation (Figure 6A).